Paul J. Clancy

2015

In 2015, Paul J. Clancy earned a total compensation of $4M as EVP, Chief Financial Officer at Biogen, a 16% decrease compared to previous year.

Compensation breakdown

Change in Pension Value and Nonqualified Deferred Compensation Earnings$45,960
Non-Equity Incentive Plan$284,655
Salary$747,498
Stock Awards$2,543,374
Other$332,115
Total$3,953,602

Clancy received $2.5M in stock awards, accounting for 64% of the total pay in 2015.

Clancy also received $46K of change in pension value and nonqualified deferred compensation earnings, $284.7K in non-equity incentive plan, $747.5K in salary and $332.1K in other compensation.

Rankings

In 2015, Paul J. Clancy's compensation ranked 2,215th out of 13,638 executives tracked by ExecPay. In other words, Clancy earned more than 83.8% of executives.

ClassificationRankingPercentile
All
2,215
out of 13,638
84th
Division
Manufacturing
793
out of 5,187
85th
Major group
Chemicals And Allied Products
283
out of 1,857
85th
Industry group
Drugs
222
out of 1,531
86th
Industry
Biological Products, Except Diagnostic Substances
38
out of 260
85th
Source: SEC filing on April 15, 2016.

Clancy's colleagues

We found six more compensation records of executives who worked with Paul J. Clancy at Biogen in 2015.

2015

George Scangos

Biogen

Chief Executive Officer

2015

John Cox

Biogen

EVP, Pharmaceutical Operations and Technology

2015

Douglas Williams

Biogen

Former EVP, Research and Development

2015

Stuart Kingsley

Biogen

Former EVP, Global Operations

2015

Susan Alexander

Biogen

Chief Legal Officer

2015

Kenneth DiPietro

Biogen

EVP, Human Resources

You may also like